CIK 0001842952 · <br>Emerging growth company
Context Therapeutics Inc.
Sign in to watch- Ticker
- CNTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 863738787
- Phone
- 267-225-7416
- Business address
- 2001 MARKET STREET, SUITE 3915 UNIT #15, PHILADELPHIA, PA, 19103
- Former names
- Context Therapeutics LLC
- 8-K Event Shareholder vote results
- 4 Open-market buy Chief Executive Officer bought 100,000 shares at $0.70 ($70,080)
- 4 Open-market buy Chief Legal Officer, Corp. Sec bought 20,000 shares at $0.58 ($11,520)
- 4 Open-market buy Chief Financial Officer bought 40,010 shares at $0.64 ($25,486)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Regulation FD disclosure · Other events
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 8-K Event Regulation FD disclosure · Other events
- PRE 14A Proxy Proxy Statement (Preliminary)
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Delisting notice
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
Page 4 of 16 · 309 filings